Skip to main content

Envoy Medical, Inc.

corporate_fare Company Profile

Envoy Medical, Inc.

COCH·NASDAQ·Life Sciences·CIK 0001840877

Envoy Medical, Inc. is a hearing health company that develops innovative medical technologies for various types of hearing loss. The company aims to provide hearing devices that leverage the ear's natural anatomy, specifically by using an implanted sensor to capture sound energy from the ossicular chain (the three small hearing bones connecting the eardrum to the cochlea). This sensor converts mechanical energy into a signal that can be processed and amplified to meet a patient's specific hearing needs. Envoy Medical's initial product, the Esteem FI-AMEI, received FDA approval in 2010. It is the only FDA-approved fully implanted active hearing implant available. Despite its unique status, the Esteem FI-AMEI faced commercial challenges, primarily because the Centers for Medicaid and Medicare Services (CMS) classified it as a hearing aid, which limited coverage eligibility. The company continues to seek proper classification for the Esteem FI-AMEI as a Fully Implanted Active Middle Ear Implant. Globally, approximately 1,000 Esteem FI-AMEI devices have been implanted, including some during clinical trials in the early 2000s. This has provided Envoy Medical with over two decades of experience with its implantable sensor technology, which has demonstrated itself as a viable alternative to external or implanted microphones.

Envoy Medical, Inc. (NASDAQ:COCH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 34 items for COCH at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Envoy Medical Reports Key Clinical Trial Progress, $32M Debt Extinguishment, and $30M Capital Raise
  • Envoy Medical Seeks Shareholder Approval for Massive Dilution from Recent Offering Warrants and New Equity Plans
  • Envoy Medical Faces Going Concern Warning Amidst Deeply Discounted $30M Offering and Nasdaq Delisting Threat; Insiders Show Conviction with $8.17M Buys
  • Envoy Medical Regains Nasdaq Compliance, Averting Delisting Threat
  • Director Mona Chetan Patel Buys $125K in Envoy Medical Stock and Warrants

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$241K
Net Income
-$23.76M
Diluted EPS
-$1.23
Op. Cash Flow
-$18.2M
Free Cash Flow
-$18.38M
Gross Profit
-$633K
Operating Income
-$22.27M
Cash & Equivalents
$3.74M
Debt / Equity
0.00×
Net Margin
-98.57×
Shares Outstanding
23.26M sh
Source: 10-K · filed 2026-04-13 · accession 0001213900-26-043011
$6.77 +0.52% today
52-week range · as of 2026-11-05 $3.63 – $9.54
Market cap
$52.4M
Volume
11.6K (0.5× avg)
3-mo avg 25.6K
Live data · 2026-11-16 18:48 UTC · Market open

show_chartPrice Chart

Loading chart...

feed COCH - Filings & News (Page 2)

COCH
Mar 27, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.6526
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
COCH
Mar 23, 2026, 4:31 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.7502
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
COCH
Mar 23, 2026, 9:26 AM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $0.7801
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
COCH
Feb 27, 2026, 9:11 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7002
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
COCH
Feb 17, 2026, 4:51 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $0.6967
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
COCH
Feb 17, 2026, 4:49 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $0.7117
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
COCH
Feb 17, 2026, 4:45 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $0.650
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
COCH
Feb 17, 2026, 1:35 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $0.58535
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
COCH
Feb 17, 2026, 9:14 AM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $0.5701
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
COCH
Feb 13, 2026, 5:17 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.5901
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
COCH
Feb 12, 2026, 8:44 AM EST
Filing Type: 424B4
Importance Score:
9
Price at Filing: $0.5866
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
COCH
Feb 12, 2026, 8:42 AM EST
Filing Type: 424B4
Importance Score:
10
Price at Filing: $0.5866
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
COCH
Feb 11, 2026, 9:13 AM EST
Filing Type: S-1MEF
Importance Score:
9
Price at Filing: $0.420
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
COCH
Feb 06, 2026, 10:58 AM EST
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.5499
Real-time Price: $6.77 info
Change: Reverse Stock Split info
Market Cap: $52.396M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets